A series of colorectal carcinomas (n = 49) resected from patients with known clinical outcomes were analysed for E-cadherin expression using in situ hybridisation to measure mRNA. Patients surviving 5 years or longer (n = 31) exhibited significantly higher levels of E-cadherin mRNA than those surviving less than 5 years (n = 18, P = 0.003). These preliminary results from this small sample suggest that E-cadherin expression may be a useful prognostic marker in colorectal cancer patients.
Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome.
S. Dorudi,A. Hanby,Richard Poulsom,J. Northover,I. R. Hart
Published 1995 in British Journal of Cancer
ABSTRACT
PUBLICATION RECORD
- Publication year
1995
- Venue
British Journal of Cancer
- Publication date
1995-03-01
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-20 of 20 references · Page 1 of 1